Cytotoxicity of doxorubicin-loaded Con A-liposomes

Drug Development Research

Volumn 67, Issue 5, 2006, Pages 430-437

  Lins Rolim Santos, Hercília Maria ^a   Brederodes De Queiroz, Fernando ^a   Souto Maior, Rosa Maria ^a   Carneiro Do Nascimento, Silene ^a   Santos Magalhães, Nereide Siela ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Con A liposomes; Cytotoxicity; Doxorubicn; Hep 2 cells; Lectin; NCI H292 cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CONCANAVALIN A; DOXORUBICIN; LECTIN; LIPOSOME;

ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONJUGATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG PENETRATION; ENCAPSULATION; HEMAGGLUTINATION; HEP 2 CELL; HUMAN; HUMAN CELL; IC 50; PHYSICAL CHEMISTRY;

EID: 33749023871     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20091     Document Type: Article

References (27)

1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbot BJ, Mayo JG, Shoemaker RH, Boyd MR. 1988. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589-601.
2. Anselem S, Gabizon A, Barenmolz Y. 1993. Optimization and upscaling of Doxorubicin containing liposomes of clinical use. J Pharm Sci 79:1045-1052.
3. Bogdanov AA, Godeeva LV, Torchilin VP, Margolis LB. 1989. Lectin-bearing liposomes: differential binding to normal and to transformed mouse fibroblasts. Exp Cell Res 181:362-374.
4. Carpenter-Green S, Huang L. 1983. Incorporation of acylated wheat germ agglutinin into liposomes. Anal Biochem 135:151-155.
5. Derksen JTP, Scherphof GL. 1985. An improved method for the covalent coupling of proteins to liposomes. Biochem Biophys Acta 814:151-155.
6. Duncan RJS, Weston PD, Wrigglesworth R. 1983. A new reagent which may be used to introduce sulphydryl groups into proteins and its use in the preparation of conjugates for immunoassay. Anal Biochem 132:68-73.
7. Francis SE, Jones M. 1990. Effect of surface-bound lectin on the release of encapsulated sugar from vesicle delivery systems. Biochem Soc Trans 18:876-877.
8. Francis SE, Hutchinson FJ, Lyle IG, Jones MN. 1992. The control of protein surface concentration on proteoliposomes. Colloid Surface 62:177-184.
9. Guterres SS, Fessi H, Barrat G, Puisieux F, Devissaguet JP. 1995. Poly (D,L-lactide) nanocapsules containing non-steroidal anti-inflammatory drugs: gastrointestinal tolerance following intravenous and oral administration. Pharm Res 12:1-3.
10. Hamaguchi T, Matsumura Y, Nakanishi Y, Muro K, Yamada Y, Shimada Y, Shirao K, Niki H, Hosokawa S, Tagawa T, Kakizoe T. 2004. Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts. Cancer Sci 95:608-613.
11. Horowitz AT, Barenholz Y, Gabizon AA. 1992. In vitro cytotoxicity of liposome-encapsulated of doxorubicin: dependence on liposome composition and drug release. Biochem Biophys Acta 1109:203-209.
12. Hutchinson FJ, Francis SE, Lyle IG, Jones MN. 1989. The characterization of liposomes with covalently attached proteins. Biochim Biophys Acta 978:17-24.
13. Hutchinson FJ, Jones MN. 1988. Lectin-mediated targeting of liposomes to a model surface-an ELISA method. FEBS Letts 234:493-496.
14. Jones MN. 2005. Use of liposomes to deliver bactericides to bacterial biofilms. Method Enzymol 391:211-228.
15. Jones MN, Francis SE, Hutchinson FJ, Handley PS, Lyle IG. 1993. Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. Biochem Biophys Acta 1147:251-261.
16. Koningsberg PJ, Godel R, Kissel T, Richer LL. 1998. The development of IL-2 conjugated liposomes for therapeutic purposes. Biochem Biophys Acta 1370:243-251.
17. Lehr CM. 2000. Lectin-mediated drug delivery: The second generation of bioadhesives. J Control Rel 65:19-29.
18. Liautard JP, Vidal M, Philipott JR. 1985. Controlled binding of liposomes to culture cells by means of lectins. Biol Int Rep 2:1123-1137.
19. Lu WL, Qi XR, Zhang Q, Li RY, Wang GL, Zhang WJ, Wei SL. 2004. A pegylated liposomal platform: Pharmacokinetics, pharmacodynamics, and tocixity in mice using doxorubicin as a model drug. J Pharmacol Sci 95:381-389.
20. Lukyanov AN, Elbauoumi TA, Chakilam AR, Torchilin VP. 2004. Tumour-targeted liposomes: Doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Control Release 100:135-144.
21. Moreira JN, Gaspar R. 2004. Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer. Braz Med Biol Res 37:1185-1192.
22. Paiva PMG, Souza AF, Oliva MLV, Kennedy JF, Cavalcanti MSM, Coelho LCBB, Sampaio CAM. 2003. Isolation of a trypsin inhibitor from Edrinodorus paniculatus seeds by affinity chromatography on immobilized Cratylia mollis isolectins. Biores Technol 88:75-79.
23. Peterson GL. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346-356.
24. Rodrigues JS, Santos-Magalhães NS, Coelho LCBB, Couvreur P, Pochel G, Gref R. 2003. Novel core (polyester)-shell (polysaccharide) nanoparticles: protein loading and surface modification with lectins. J Control Release 92:103-112.
25. Santos-Magalhães NS, Cave G, Siller M, Benita S. 1991. The stability and in vitro release kinetics of a clofibride emulsion. Int J Pharm 76:225-237.
26. Sharon N. 1993. Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem Sci 18:221-226.
27. Vyas SP, Sihorkar V, Dubey PK. 2001. Preparation, characterization and in vitro antimicrobial activity of metronidazol bearing lectinized liposomes for intra-periodontal pocket delivery. Pharmazie 56:7:254-260.